ATLANTA - Clinical trials already proved how effective Pfizer and Moderna’s vaccines are at stopping the spread of COVID-19, and that data was reaffirmed on Wednesday when the U.S.
Centers for Disease Control and Prevention (CDC) revealed the results of its three-month real-world study of the two vaccines in patients 65 and older.The CDC’s study found the shots are 94% effective at preventing hospitalizations for fully vaccinated adults and 64% effective among partially vaccinated adults 65 and older.These numbers mirror what was revealed in clinical trials last year, which showed Pfizer’s vaccine is 95% effective and Moderna’s is 94.5%."These findings are encouraging and welcome news for the two-thirds of people aged 65 and up who are.